This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This CYP4V2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 496-525 amino acids from the C-terminal region of human CYP4V2.
CYP4V2
Reaktivität: Human
WB, ELISA
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
For WB starting dilution is: 1:1000
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.3 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
CYP4V2
(Cytochrome P450, Family 4, Subfamily V, Polypeptide 2 (CYP4V2))
BCD antikoerper, CYP4AH1 antikoerper, CYP4V antikoerper, bcd antikoerper, cyp4ah1 antikoerper, MGC147146 antikoerper, cytochrome P450 family 4 subfamily V member 2 antikoerper, cytochrome P450 family 4 subfamily V member 2 S homeolog antikoerper, cytochrome P450, family 4, subfamily V, polypeptide 2 antikoerper, cytochrome P450, family 4, subfamily v, polypeptide 2 antikoerper, CYP4V2 antikoerper, cyp4v2.S antikoerper, cyp4v2 antikoerper
Hintergrund
This gene encodes a member of the cytochrome P450 hemethiolate protein superfamily which are involved in oxidizing various substrates in the metabolic pathway. It is implicated in the metabolism of fatty acid precursors into n-3 polyunsaturated fatty acids.